Pooling the complex survey data across the 64 lower and middle-income countries: A study on antibiotic usage in

Md Fakrul Islam1, Prosenjit Basak Arka1, Mahfuzer Rohman1

  • 1Biostatistics, Epidemiology and Public Health Research Team, Department of Statistics, Shahjalal University of Science and Technology, Sylhet, 3114, Bangladesh.

Heliyon
|January 21, 2025
PubMed

Insights

Antibiotic exposure for children under five with fever/cough is moderate in low- and middle-income countries (LMICs), but varies widely. Educated mothers and richer households show higher exposure rates, warranting further investigation into antibiotic stewardship.

Area of Science:

  • Global Health
  • Pediatrics
  • Pharmacology

Background:

  • Rising antibiotic exposure for pediatric fever/cough in low- and middle-income countries (LMICs).
  • Concerns over escalating healthcare costs and antimicrobial resistance.
  • Need to identify factors influencing antibiotic use and at-risk populations.

Purpose of the Study:

  • To analyze antibiotic exposure for fever/cough in children under five across 64 LMICs.
  • To identify demographic and socioeconomic factors associated with antibiotic exposure.
  • To highlight disparities in antibiotic use among LMICs.

Main Methods:

  • Utilized recent Demographic and Health Survey (DHS) data from 64 LMICs.
  • Employed descriptive statistics and binary logistic regression analysis.
  • Geospatial analysis conducted using ArcGIS.

Main Results:

  • 30.4% of children under five with fever/cough received antibiotics.
  • Highest prevalence in Congo (68.7%), Egypt (65.5%), Tajikistan (61.8%); lowest in Cameroon (0.3%), Armenia (4.0%), Mauritania (6.1%).
  • Mothers with higher education and children in richer households had increased odds of antibiotic exposure.

Conclusions:

  • Moderate overall antibiotic exposure for fever/cough in LMIC children, with significant country-level variations.
  • Higher maternal education and household wealth are linked to increased antibiotic exposure.
  • Countries with high/low exposure rates should investigate potential antibiotic abuse or healthcare service gaps.
Abstract